Ambulatory management of pre- and extensively drug resistant tuberculosis patients with imipenem delivered through port-a-cath: A mixed methods study on treatment outcomes and challenges.
Vijay Vinayak ChavanAlpa DalalSharath NagarajaPruthu ThekkurHoma MansoorAugusto MeneguimRoma ParyaniPramila SinghStobdan KalonMrinalini DasGabriella FerlazzoPetros IsaakidisPublished in: PloS one (2020)
Administration of imipenem was feasible through port-a-cath. Though outcomes with ambulatory based imipenem containing regimens were promising, there were several challenges in providing care. The feasibility of infusion at day care facilities needs to explored to overcome challenges in infusion at patients home.
Keyphrases
- drug resistant
- multidrug resistant
- healthcare
- blood pressure
- end stage renal disease
- palliative care
- acinetobacter baumannii
- low dose
- newly diagnosed
- quality improvement
- ejection fraction
- chronic kidney disease
- prognostic factors
- robot assisted
- affordable care act
- emergency department
- pain management
- patient reported outcomes
- laparoscopic surgery
- type diabetes
- health insurance
- pulmonary tuberculosis
- cystic fibrosis
- chronic pain
- minimally invasive